After completing the hepatitis B vaccination series, which hepatitis B serology panel results confirm vaccine‑induced immunity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Confirming Hepatitis B Vaccine Immunity

You have immunity to hepatitis B from vaccination if your anti-HBs (hepatitis B surface antibody) level is ≥10 mIU/mL when tested 1–2 months after completing the vaccine series. 1, 2

What Test to Order

Order a quantitative anti-HBs test using an assay such as ELISA that can detect the protective threshold of ≥10 mIU/mL. 1, 2 This single test is sufficient if you have documented completion of the vaccine series and no risk factors for hepatitis B infection. 1

Interpreting Your Results

If anti-HBs ≥10 mIU/mL:

  • You are immune and protected. 1, 2, 3
  • No further testing or booster doses are needed if you are immunocompetent. 1, 2, 3
  • Protection persists for 30+ years and likely for life, even when antibody levels later decline below 10 mIU/mL, because immune memory cells maintain protection. 2, 3

If anti-HBs <10 mIU/mL:

  • You are considered a non-responder to the initial vaccine series and susceptible to infection. 1, 3
  • Receive one booster dose of hepatitis B vaccine immediately, then retest anti-HBs 1–2 months later. 1, 3
  • If anti-HBs remains <10 mIU/mL after the booster, complete a full second 3-dose vaccine series (at 0,1, and 6 months), then retest 1–2 months after the final dose. 1, 3
  • After completing 6 total doses, if still non-responsive, test for HBsAg and anti-HBc to rule out chronic hepatitis B infection. 1, 4

Timing of Testing

Test 1–2 months after your final vaccine dose. 1, 2, 3 Testing earlier may show falsely low levels because peak antibody response has not yet occurred. 1 Testing later than 6 months is acceptable but may show naturally declining levels that do not reflect lack of immunity. 1

Special Populations Requiring Testing

Post-vaccination testing is specifically recommended for: 1, 3

  • Healthcare workers and public safety personnel with blood/body fluid exposure risk
  • Hemodialysis patients
  • HIV-infected or immunocompromised persons
  • Sexual partners of HBsAg-positive persons
  • Infants born to HBsAg-positive mothers

Common Pitfalls

Do not confuse different hepatitis B tests. 2, 3 The three main markers are:

  • Anti-HBs (hepatitis B surface antibody): Indicates immunity from vaccination or past infection
  • HBsAg (hepatitis B surface antigen): Indicates current infection
  • Anti-HBc (hepatitis B core antibody): Indicates past or current infection, but NOT present after vaccination alone

A pattern of anti-HBs positive + HBsAg negative + anti-HBc negative confirms vaccine-derived immunity. 3 If you only have anti-HBs positive, you are immune from vaccination. 3

Do not retest or get boosters if you are immunocompetent and initially responded with anti-HBs ≥10 mIU/mL. 2, 3 Even if your antibody level later drops below 10 mIU/mL, you remain protected through immune memory. 2, 3

Immunocompromised Patients

If you are immunocompromised (HIV infection, chemotherapy, hemodialysis, transplant recipient), you require: 1, 2, 3

  • Annual anti-HBs testing
  • Booster doses when levels decline to <10 mIU/mL
  • Higher vaccine doses (40 μg instead of standard 10–20 μg) may be needed initially 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatitis B Immunity Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hepatitis B Immunity Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pre-Employment Hepatitis B Screening and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the difference between antibody to hepatitis B surface antigen (anti‑HBs) and total antibody to hepatitis B core antigen (anti‑HBc), and how are the serologic patterns interpreted?
What is the recommended schedule for anti-hepatitis (hep) booster doses in an adult or adolescent with a normal immune status who has previously received a hepatitis A or hepatitis B vaccine?
What are the management and prevention strategies for a patient with no serological evidence of hepatitis B immunity and a history of past hepatitis A infection or immunization?
Does a patient with non-reactive hepatitis B (HB) surface antigen and non-reactive hepatitis B (HB) antibody, and no evidence of hepatitis B virus (HBV) infection, have immunity to hepatitis B?
What is the hepatitis status of a 22-year-old woman with no previous exposure to hepatitis B, no jaundice, positive Hepatitis B surface (HBS) antigen, positive Immunoglobulin G (IgG) antibody to Hepatitis B core (anti-HBC), elevated Hepatitis B deoxyribonucleic acid (HBDNA) levels, and positive Hepatitis B envelope (HB) antigen?
What additional psychiatric interventions are recommended for a 67‑year‑old Caucasian female with bipolar disorder, allergic to lithium, quetiapine, and valproic acid, currently receiving olanzapine 10 mg daily, fluoxetine 40 mg daily, and lorazepam 1.5 mg three times daily, who remains paranoid and in an acute mental breakdown?
Why is a cervical cerclage placed at 13–16 weeks gestation?
What is the likely diagnosis and recommended management for a non‑pruritic, patchy rash on the trunk and arms?
What is the appropriate acute management for a 66‑year‑old man with chronic bipolar disorder in a depressive phase presenting with suicidal ideation?
In a 32‑year‑old with mild‑to‑moderate primary‑prevention dyslipidaemia, must a low‑intensity statin (e.g., atorvastatin 10 mg) or fenofibrate be continued lifelong, or can it be discontinued after lipid normalization with lifestyle measures?
How do I evaluate and manage a patient presenting with loss of consciousness (syncope)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.